
1. General Information
CELLMUNE 500 MG is an oral immunosuppressant containing mycophenolate mofetil. It reduces certain immune-system responses that can cause the body to attack a transplanted organ. Cipla's product information specifies CELLMUNE 500 as a film-coated tablet containing 500 mg mycophenolate mofetil.
Manufacturer: Cipla Ltd.
Active ingredient: Mycophenolate mofetil 500 mg
Dosage form: Film-coated tablet
Therapeutic class: Immunosuppressant
Prescription status: Prescription medicine
Typical pack: 10 tablets per blister strip, according to Cipla's product information.
2. Product Information
CELLMUNE 500 MG is designed to reduce excessive immune activity following organ transplantation. The medicine is commonly used as part of a combination immunosuppressive regimen, often alongside medicines such as corticosteroids and, depending on the transplant protocol, other immunosuppressants.
It should be stored protected from light and moisture at a temperature not exceeding 30°C, and kept out of reach of children.
3. Uses of CELLMUNE 500 MG
CELLMUNE 500 MG may be prescribed for:
- Prevention of rejection following kidney transplantation
- Prevention of rejection following liver transplantation
- Prevention of rejection following heart transplantation
- In selected cases, treatment of refractory organ rejection under specialist supervision.
4. Benefits of This Medicine
The principal benefit of CELLMUNE 500 MG is its ability to reduce the immune response against a transplanted organ.
Potential benefits include:
- Helps reduce the risk of organ rejection.
- Supports continued function of the transplanted organ.
- Forms part of long-term immunosuppressive treatment after transplantation.
- Can help improve graft survival when appropriately combined with other prescribed medicines.
5. Side Effects of CELLMUNE 500 MG
Because CELLMUNE suppresses the immune system, it can increase susceptibility to infections and can affect blood-cell counts. Possible adverse effects include:
- Diarrhea
- Vomiting or nausea
- Headache
- Abdominal discomfort
- Bacterial, viral or fungal infections
- Reduced white blood-cell counts
- Anemia
- Increased blood pressure
- Dizziness and other gastrointestinal symptoms.
Some effects can be serious. Unusual bleeding or bruising, persistent fever, sore throat, mouth ulcers, or other signs of infection should be reported promptly to the treating physician.
6. Common Side Effects
Commonly reported effects can include:
- Diarrhea
- Vomiting
- Nausea
- Headache
- Abdominal pain
- Infections
- Changes in white blood-cell counts.
Not everyone experiences these effects, and the severity can vary from person to person.
7. How to Use CELLMUNE 500 MG
Take CELLMUNE exactly as prescribed by the transplant specialist.
- Swallow the tablet whole with water.
- Do not crush, chew or break the tablet.
- Follow the prescribed dose and schedule consistently.
- Product information commonly recommends administration on an empty stomach, with the exact instructions determined by the treating physician.
- Do not stop treatment suddenly without consulting your doctor, even if you feel well.
- Do not change from mycophenolate mofetil to another formulation of mycophenolic acid without medical supervision.
8. How CELLMUNE 500 MG Works
Mycophenolate mofetil is converted to mycophenolic acid, which inhibits an enzyme called inosine monophosphate dehydrogenase (IMPDH).
This limits the ability of certain lymphocytes—important cells involved in immune responses—to multiply. As a result, the immune response is reduced, making it less likely that the body's immune system will attack and reject the transplanted organ.
9. Safety Advice
Important: CELLMUNE 500 MG should be used only under appropriate medical supervision. Cipla specifically states that it should not be used without supervision by a physician experienced in immunosuppressive therapy.
- Pregnancy: Mycophenolate mofetil can cause serious fetal harm and increase the risk of pregnancy loss and birth defects. Women who could become pregnant require appropriate pregnancy-prevention measures and medical counseling.
- Infections: The medicine suppresses immunity and can increase susceptibility to infections. Seek medical advice promptly for fever or other infection symptoms.
- Blood tests: Doctors may monitor blood-cell counts and other parameters during treatment.
- Sun exposure: Immunosuppressive treatment can increase the risk of certain skin cancers, so appropriate sun protection is advisable.
- Breastfeeding: Discuss breastfeeding with your physician before taking mycophenolate mofetil.
- Drug interactions: Inform your doctor about all prescription medicines, OTC medicines, supplements and herbal products you use.
- Do not self-medicate: Dose adjustments should be made only by the treating transplant specialist.
10. FAQs
Q1. What is CELLMUNE 500 MG used for?
It is primarily used with other immunosuppressive medicines to prevent rejection of transplanted organs such as the kidney, liver and heart.
Q2. What is the active ingredient in CELLMUNE 500 MG?
Each tablet contains mycophenolate mofetil 500 mg.
Q3. Is CELLMUNE 500 MG a prescription medicine?
Yes. It requires medical supervision, particularly because it is a potent immunosuppressant.
Q4. Can I stop CELLMUNE if I feel better?
No. Transplant patients should not stop or alter immunosuppressive treatment without consulting their transplant physician.
Q5. Can CELLMUNE 500 MG cause infections?
Yes. Because it suppresses immune function, it can increase susceptibility to bacterial, viral and fungal infections.
Q6. Can CELLMUNE be taken during pregnancy?
Mycophenolate mofetil carries significant pregnancy risks, including miscarriage and birth defects. Women who are pregnant, planning pregnancy, or capable of becoming pregnant should discuss this medicine with their doctor.
Q7. How should CELLMUNE 500 MG be stored?
Store it protected from light and moisture at temperatures not exceeding 30°C and keep it away from children.
11. Substitutes for CELLMUNE 500 MG
Several products contain the same active ingredient (mycophenolate mofetil 500 mg), but they should not be substituted without approval from the treating physician, particularly in transplant patients.
Examples listed as alternatives include:
- Mycept 500 Tablet
- Mycofit 500 Tablet
- Mofilet 500 Tablet
- Renodapt 500 Tablet
- Mofetyl 500 Tablet.
The exact brand, formulation and availability can vary by country. For international supply, regulatory approval and prescription requirements should be checked in the destination country.
12. SEO / B2B Keywords
Primary Keywords:
- Cellmune 500 mg Tablets
- Cellmune 500 mg exporter
- Cellmune 500 mg supplier
- Cellmune 500 mg wholesaler
- Mycophenolate Mofetil 500 mg Tablets
- Mycophenolate Mofetil 500 mg exporter
- Mycophenolate Mofetil 500 mg supplier
- Cipla Cellmune 500 mg
- Cellmune 500 mg pharmaceutical supplier
- Cellmune 500 mg medicine exporter
Long-Tail B2B Keywords:
- Buy Cellmune 500 mg Tablets from India
- Cellmune 500 mg wholesale supplier from India
- Cellmune 500 mg pharmaceutical exporter from Nagpur India
- Mycophenolate Mofetil 500 mg tablets wholesale supplier India
- Cellmune 500 mg medicine supplier for international buyers
- Cellmune 500 mg tablets bulk supply from India
- Cellmune 500 mg tablets exporter to USA
- Cellmune 500 mg tablets exporter to UK
- Cellmune 500 mg tablets exporter to Australia
- Cellmune 500 mg tablets exporter to Canada
- Cellmune 500 mg tablets exporter to Singapore
- Cellmune 500 mg tablets exporter to South Korea
- Cellmune 500 mg tablets exporter to UAE
- Mycophenolate Mofetil 500 mg exporter from Nagpur
- Pharmaceutical medicine exporter from Nagpur India
- Prescription medicine wholesale supplier India
- Immunosuppressant medicine exporter India
- Organ transplant medicine supplier India
- International pharmaceutical supplier for Cellmune 500 mg
Keywords







